Press Release: Wockhardt : New market study, "Wockhardt Limited (WOCKPHARMA) - Financial and Strategic SWOT Analysis Review", has been published

( Wockhardt Limited (Wockhardt), a subsidiary of Khorakiwala Holdings and Investments Private Limited is a pharmaceutical and biotechnology company. It carries out research, development, manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, vaccines and active pharmaceutical ingredients (APIs). The company's product portfolio includes prescription drugs, over-the-counter pharmaceuticals and APIs for the treatment of diseases in the areas of orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, and diabetes. Wockhardt operates a chain of eight super-specialty hospitals which offers comprehensive end to end care in areas of cardiology, cardiac surgery, neurology, neurosurgery, orthopedics and joint replacement surgery. The company ..

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Habil Khorakiwala's photo - Founder & CEO of Wockhardt

Founder & CEO

Habil Khorakiwala

CEO Approval Rating


Wockhardt is a pharmaceutical and biotechnology firm that manufactures injectables and lyophilised products. Read more